AU5260900A - Implant, method for producing the implant, and use of the implant - Google Patents
Implant, method for producing the implant, and use of the implant Download PDFInfo
- Publication number
- AU5260900A AU5260900A AU52609/00A AU5260900A AU5260900A AU 5260900 A AU5260900 A AU 5260900A AU 52609/00 A AU52609/00 A AU 52609/00A AU 5260900 A AU5260900 A AU 5260900A AU 5260900 A AU5260900 A AU 5260900A
- Authority
- AU
- Australia
- Prior art keywords
- bone
- implant
- substance
- titanium
- oxide layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 title claims abstract description 139
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000011148 porous material Substances 0.000 claims abstract description 88
- 239000000126 substance Substances 0.000 claims abstract description 73
- 239000010936 titanium Substances 0.000 claims abstract description 48
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 48
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 47
- 230000006870 function Effects 0.000 claims abstract description 33
- 230000008468 bone growth Effects 0.000 claims abstract description 20
- 210000001519 tissue Anatomy 0.000 claims abstract description 19
- 230000008467 tissue growth Effects 0.000 claims abstract description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 45
- 239000003792 electrolyte Substances 0.000 claims description 26
- 230000008569 process Effects 0.000 claims description 25
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 24
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 18
- 230000003647 oxidation Effects 0.000 claims description 15
- 238000007254 oxidation reaction Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 230000003746 surface roughness Effects 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000003754 machining Methods 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 230000003111 delayed effect Effects 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 description 84
- 239000000463 material Substances 0.000 description 16
- 238000010348 incorporation Methods 0.000 description 15
- 230000000975 bioactive effect Effects 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000012876 topography Methods 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000002344 surface layer Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 108060003393 Granulin Proteins 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000002805 bone matrix Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000003411 electrode reaction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000007514 turning Methods 0.000 description 2
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940125368 controlled substance Drugs 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003608 titanium Chemical class 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0004—Consolidating natural teeth
- A61C8/0006—Periodontal tissue or bone regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
- A61C8/0015—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating being a conversion layer, e.g. oxide layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2803—Bones for mandibular reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30011—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30036—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in release or diffusion time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/3085—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with a threaded, e.g. self-tapping, bone-engaging surface, e.g. external surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/30925—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth etched
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0035—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in release or diffusion time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00598—Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
- A61F2310/00616—Coating made of titanium oxide or hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00976—Coating or prosthesis-covering structure made of proteins or of polypeptides, e.g. of bone morphogenic proteins BMP or of transforming growth factors TGF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Dentistry (AREA)
- Ceramic Engineering (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
An implant that includes titanium and has one or more surfaces which can be applied in or on a bone growth area. One or more of the surfaces are arranged with a depot for bone-growth-initiating or bone-growth-stimulating substance, in which the depot is formed by a pore arrangement in a relatively thick oxide layer on the titanium. The substance is acted on, for a considerable period of time, by one or more release functions for the substance which permit a controlled or optimized release of substance to the surrounding tissue or bone growth area.
Description
WO 00/72777 PCT/SEOO/01027 TITLE Implant, method for producing the implant, and use of 5 the implant TECHNICAL FIELD The present invention relates to an implant which can be used in dentistry, for example. The 10 implant comprises or consists of titanium and has one or more surfaces which can be applied in or on one or more bone growth areas. One or more of the said surfaces are arranged with a depot for bone-growth initiating or bone-growth-stimulating substance TS, for 15 example BMP (e.g. type 2 or type 4), where BMP stands for Bone Morphogenetic Proteins, and which depot is formed by a pore arrangement in a relatively thick oxide layer on the titanium. The invention also relates to an implant for 20 application in a hole formed in bone, for example the jaw bone. It also relates to a method for producing an implant intended to be applied in a hole of the said type. The invention also concerns the use of a highly porous and thick titanium oxide layer to which a bone 25 growth-initiating and/or a bone-growth-stimulating substance, preferably in the form of BMP, has been added. The invention also relates to a method for producing, on an implant comprising or consisting of 30 titanium, and by means of anodic oxidation, relatively thick oxide layers on one or more titanium surfaces which are intended to be placed against or arranged adjacent to one or more bone growth areas. At least part or parts bearing the said surface or surfaces 35 is/are intended to be prepared and immersed in electrolyte, and the implant is brought into contact with an electrical energy source above the electrolyte surface, and the oxidation process is established by also connecting to the energy source a counter- WO 00/72777 PCT/SEOO/01027 -2 electrode which is arranged in the electrolyte. PRIOR ART It is already known that, under certain 5 conditions, implants made of commercially pure (99.6%) titanium permit incorporation of surrounding bone tissue so that intimate contact can be obtained between implant and tissue. The intimate contact between the implant and normal bone tissue, often referred to as 10 osseointegration, in turn permits good and permanent anchoring of the implant, which can be used in various clinical treatment situations. Titanium implants anchored in bone can be used as securing elements for tooth replacements and tooth prostheses, or for other 15 types of prostheses or devices (cf. finger joints, prosthetic eyes, prosthetic ears, hearing aids). The reason for the good bone incorporation results which are achieved in particular with titanium implants produced by turning or milling can be seen to lie in 20 the favourable combination of structure (topography and surface roughness) and chemical compositions to which the manufacturing method gives rise. In this connection, reference may be made to Swedish Patent 7902035-0. The abovementioned titanium surfaces 25 typically have a surface roughness (Ra) in the range of 0.1 - 1 pm. The chemical composition of the surface is essentially titanium dioxide (TiO 2 ) which is present in the form of a thin (< 10 nm) oxide layer. The surface is also indicated as having a porosity in the range of 30 10 - 1000 nm. If the pore density of the previously known surfaces is studied more closely under a scanning electron microscope, it emerges that the pore density of these surfaces is relatively low, and that the pore depth in the oxide can never exceed 10 nm. 35 A number of experimental studies have been conducted in order to investigate bone incorporation around types of titanium surfaces other than those which have been turned or milled. In these studies, different surface preparation methods have been used to WO 00/72777 PCT/SEOO/01027 -3 modify various properties, such as surface topography, oxide thickness, surface composition, etc., of the titanium surfaces. Examples of methods which may be used for modifying the surface topography of titanium 5 implants are: sand-blasting, plasma spraying, particle sintering, electro-polishing, and anodic oxidation. The results from these studies show that the surface topography at different levels can affect bone incorporation and the mechanical anchoring of the 10 implant, both in terms of quality and quantity, cf. the said patent specification. It has been shown, for example, that threaded titanium implants with sand blasted surfaces and with surface roughness (Ra) at the micrometre level can give rise to higher twisting 15 forces than surfaces which have only been turned or milled. It has also been demonstrated that certain types of electrochemically modified titanium surfaces can give rise to more rapid bone incorporation than the titanium surfaces which have been turned or milled. 20 The reason for this improvement probably lies in a combination of a more favourable surface topography and a greater oxide thickness. The last-mentioned surfaces can be considered to be heterogeneous and consist essentially of smooth areas with a relatively dense 25 oxide (TiO 2 ), and a minority of the areas having a surface roughness and a certain oxide porosity at the level of about 1 JLm. The increased oxide thickness of these surfaces, about 200 nm, can be expected to result in an improved corrosion resistance of the material, 30 and thus a favourable effect on account of the lower rate of titanium ion release. Against the background of the known facts set out above, it is thus possible to advance the hypothesis that a high oxide porosity and high oxide 35 thickness can have a positive effect on the rate of bone incorporation around titanium implants. It is also known that the biological processes surrounding incorporation in connection with the said implants can be influenced by using various types of substances.
WO 00/72777 PCT/SEOO/01027 -4 Thus, it is known that the rate at which bone is formed can be affected to a large extent by growth factors which are produced by means of substances which initiate or stimulate bone growth. Examples which may 5 be mentioned are substances belonging to the super family TGF-, and other bone matrix proteins. It is known per se to produce different types of porous surfaces or layers from titanium-based material. Reference may be made, inter alia, to the 10 article published by Dunn et al. and entitled "Gentamicin sulfate attachment and release from anodized TI-6A1-4V orthopedic materials" in "Journal of Biomedical Materials Research, Vol. 27, 895-900 (1993)". 15 In this article, general reference is made to the fact that it is possible to produce porous titanium and oxide layers using so-called anodic oxidation, which is an electrochemical process. In this connection, it is proposed that the layer or layers be 20 used as a depot or store for antibiotic substances. Reference may also be made to the article "Formation and characterization of anodic titanium oxide films containing Ca and P" by Hitoshi Ishizawa and Makoto Ogino in "Journal of Biomedical Materials 25 Research, Vol. 29, 65-72 (1995)". This article shows that it is already known to use an electrochemical process to produce relatively thick titanium oxide layers provided with a pore arrangement which gives the layers a highly porous structure. It is also mentioned 30 in this connection that the layers can be used as supports for substance for rapid bone growth. Porous surface layers have thus previously been produced on titanium surfaces intended as implant material. In most cases, however, the aim of this 35 preparation has been other than that concerned in the present invention. Thus, it has previously been proposed to develop calcium-containing and phosphorus containing oxide layers which, by means of further treatment, can be made to precipitate hydroxyapatite WO 00/72777 PCT/SEOO/01027 -5 crystals on the oxide layer. Reference may also be made to US Patent Specifications 4,330,891 and 5,354,390 and to European Patent Specification 95102381.1 (676 179). 5 DESCRIPTION OF THE INVENTION TECHNICAL PROBLEM In implants of the type in question here, there is a need to achieve shorter incorporation processes between bone and implant, especially in the case of 10 soft bone structures or bone qualities. The properties of the titanium material and of the growth substance must be used as far as possible to achieve this. The invention is based, inter alia, on this problem. It is known per se to use implants with a screw 15 connection to be anchored in the jaw bone. In this regard, it is known that the quality of the jaw bone can vary considerably. In the inner parts of the jaw bone in particular, the bone material can be extremely soft and/or present relatively thin trabeculae. In such 20 cases, it is preferable to be able to effect reliable implant attachments. The invention also solves this problem and proposes effective implants and methods for anchoring the implants in soft bone material too. In connection with the invention, methods are 25 used for producing the relatively thick and porous material. In this regard, it is important that clear and effective methods can be used. The invention solves this problem too. Previous methods and arrangements were based on 30 the problem of bone growth on the implant, and less consideration was given to the interaction between the implant and the bone material in question. It is important to establish an effective bioactive surface between the implant and the dentine or equivalent bone. 35 The invention solves this problem too. It is also important to achieve an effective formation of substance in the porous surface or the structure which is to function as a depot for the WO 00/72777 PCT/SEOO/01027 -6 growth substance in question. The invention solves this problem too. It is of great advantage that the porous structure functioning as depot for growth-initiating or 5 growth-stimulating substance can intervene, in a controlled manner, in the release of the substance during a desired or predetermined period of time. It can thus be advantageous to have a better controlled substance release during a certain time span which can 10 be chosen depending on the case in question. The invention solves this problem too. It is of great advantage in practice to be able to advance the implant technique a further stage in the technical field, where the practical application uses 15 bioactive surfaces instead of simply the properties of the titanium material itself, as was previously the case. By stimulating bone growth in connection with implants, it is possible, in the field of dentistry, among others, to create possibilities for controlling 20 and improving the problems of incorporation. The invention solves this problem too. It has been shown that one can expect effective incorporation processes in connection with implants for application in holes made in bone, primarily in the jaw 25 bone. By delivering one or more bioactive substances directly into a surrounding tissue or bone environment which is to be strengthened, stimulation factors can be effectively achieved. The invention is intended in particular to solve this problem too. 30 Implants for holes made in the jaw bone are in most cases provided with one or more threads via which the implant is to be mechanically anchored in the hole by means of screwing. Providing a certain degree of irregularity on the surface structure which is to be 35 screwed in imposes requirements in terms of greater screwing forces, which in themselves must not counteract the support function for the bioactive substance. The invention solves this problem too.
WO 00/72777 PCT/SE00/01027 -- 7 It is known that the jaw bone status varies considerably from one case to another and that, in the case of soft and/or thin jaw bone, it is important to be able to create arrangements which strengthen the 5 bone growth in these areas. The invention aims to solve this problem too. To create a high degree of porosity in the oxide layer in question, it is important to use the correct oxidation processes. These can be crucial in 10 determining whether or not one succeeds in achieving the desired results. The invention solves this problem too. SOLUTION 15 The feature which can principally be regarded as characterizing an implant according to the invention is that the substance, for a period of time which can be between 1 and 2 weeks, for example, is acted on by one or more release functions which permit a controlled 20 or optimal release of substance to the respective surrounding tissue or tissue/bone growth areas. If the incorporation function or bone growth function is promoted by this, other substance release processes can also be established. 25 In one illustrative embodiment, the implant works with more than one, i.e. two or more, release arrangements which are produced by means of different pore arrangements within one or more areas of one or more of the initially mentioned surfaces. Pores with 30 different pore characteristics can be used. Thus, for example, open or more or less closed pores, different pore depths, different pore densities, etc., can be arranged within one or more areas of the said surfaces. The different areas can also be provided with different 35 pore characteristics. It is also important that the oxide layer on the titanium is composed in an advantageous manner. In one embodiment, the surface of the oxide layer will comprise about 20% titanium, about 55% oxygen and about WO 00/72777 PCT/SEOO/01027 20% carbon. The oxide layer as such will be highly porous. In a preferred embodiment, the implant is of the type which comprises one or more threads. The 5 implant will bear the said oxide layers or surfaces at least in connection with the said threads. In a preferred embodiment, the oxide layer has a surface roughness of about 1 - 5 pm or less, and has a thickness preferably in the range of 2 - 10 pm. The 10 oxide layer must be highly porous, with pore diameters in the range of 0.01 - 10 pm. Another feature which can principally be regarded as characterizing an implant is that it comprises a titanium portion which can cooperate with a 15 hole formed in a bone, and that the titanium portion is designed with one or more very thick titanium oxide layers having surfaces which can be placed against the bone in the hole formation. Further characteristics are that each oxide layer is provided with a pore 20 arrangement which functions as a depot for bone-growth initiating and/or bone-growth-stimulating substance, and that, when the depot is filled with substance and the implant is in position in the hole, a release function for releasing the substance to the surrounding 25 tissue or bone comes into operation. The release function can be controlled for a chosen, essentially protracted period of time. The release function can be controlled by the choice of pore arrangement and pore characteristics in or on the 30 said layer. The feature which can principally be regarded as characterizing a method according to the invention is that the implant is produced, for example by means of machining, with a portion made of titanium which has 35 surfaces which can be placed against the bone when the implant is in position in the hole. The said titanium on the said surface or surfaces is subjected to anodic oxidation to an extent which gives a highly porous and relatively thick oxide layer on each surface concerned.
WO 00/72777 PCT/SEOO/01027 -9 A bone-growth-initiating or bone-growth-stimulating substance TS, which can be BMP, is applied to the said porous and thick layers, for example by saturation or by immersion in or dropping on and/or painting on of 5 the substance. The implant is placed in its position in the hole, resulting in the process of release of the substance to the bone being started upon insertion, the process being triggered by components in the tissue and/or bone. 10 In one embodiment, the implant, at the part or parts bearing the said surfaces, is provided with one or more threads, via which the implant is screwed into the bone. In one embodiment, the oxidized layer and its associated pore system are immersed for a chosen time, 15 for example 1 hour, in a container holding the substance, so that effective penetration of the substance into the porous layer takes place. The novel use according to the invention is characterized in that the highly porous and thick 20 titanium oxide layer, to which bone-growth-initiating or bone-growth-stimulating substance has been added, is used on implants which can be inserted into holes in bone, preferably the jaw bone. In a preferred embodiment, the use is 25 characterized in that the porous layer with added substance is used on implants with thread or threads, joint implants, etc. Another feature which can principally be regarded as characterizing an implant according to the 30 invention is that the oxide layer has a thickness in the range of 1 - 20 pm, preferably 2 - 20 pm. In a preferred embodiment, the oxide layer has a surface roughness in a range of 0.4 - 5 pim. In a further preferred embodiment, the oxide layer is highly porous, 35 with a pore number of 1 x 107 - 1 x 10 pores/cm 2 . Each surface essentially has pores with diameter sizes in the range of 0.1 - 10 pm. The total pore volume is preferably within the range of 5 x 10-2 to 10-5 cm 3
.
WO 00/72777 PCT/SEOO/01027 - 10 A method for carrying out the abovementioned anodic oxidation can principally be regarded as being characterized by the fact that diluted inorganic acids and/or diluted organic acids and/or small quantities of 5 hydrofluoric acid or hydrogen peroxide are added to the electrolytic composition, and the energy source is chosen to operate at a voltage value or voltage values in the range of 150 - 400 volts. In one embodiment, the voltage can be varied 10 for the same implant at different times in order to create different pore sizes within the same surface areas. In addition, the position of the implant in the electrolyte can be changed, together with the composition of the electrolyte and/or the voltage, in 15 order to create areas with different layer thicknesses, porosities or pore characteristics on the implant. ADVANTAGES By means of what has been described above, a 20 new dimension in implantation techniques is achieved, especially in the area of dentistry. Earlier clinical trials which opened up the way to using bioactive substances can now be given practical application, especially in connection with holes made in bone of low 25 quality with respect to hardness and of low quantity. The invention affords particular advantages in the case of implants applied in holes made in the jaw bone, where the bioactive substance can be given controlled diffusion functions (concentration diffusions) into the 30 surrounding bone material. The incorporation and bone growth period can be controlled and enhanced by a combination of the titanium material itself, the geometrical shape of the implant, and the bioactive substance. Economically advantageous methods can be 35 established on the market, and prepared implants and packages can be made commercially available. Alternatively, the substance and the implant (with its specific porous oxide layer character) can be made WO 00/72777 PCT/SEOO/01027 - 11 available separately and then assembled in situ according to instructions. 5 DESCRIPTION OF THE FIGURES A presently proposed embodiment of an arrangement, method and use according to the invention will be described below with reference to the attached drawings, in which: 10 Figure 1 shows, in vertical section, parts of a threaded implant anchored by screwing in a jaw bone, Figure la shows, in vertical section and with partial surface enlargement, a thread of the implant according to Figure 1, with an oxide layer having been 15 established on the thread surface, Figure lb shows from the side, and in vertical section, part of the implant according to Figures 1 and la which has been partially immersed in bioactive substance, the porous layer being saturated with the 20 substance in question, Figure 2 shows, in diagram form, the release function for bioactive material deposited in the oxide layer, Figure 3 shows, in perspective, and in a 25 greatly enlarged view, parts of a porous titanium oxide layer on an implant according to Figure 1, Figure 4 shows, in perspective, parts of a second porous titanium oxide layer according to Figure 1, 30 Figure 5 shows, in diagram form, the pore diameter sizes and the pore number in the layer according to Figure 3, Figure 6 shows, from above, a first embodiment of the pore character of the oxide layer, produced 35 using a combination of electrolyte, oxidation energy and time, Figure 7 shows, from above, a second embodiment of the pore character of the titanium oxide, WO 00/72777 PCT/SE00/01027 - 12 Figure 8 shows a side view of equipment for anodic oxidation of an implant according to Figure 1, Figure 9 shows, in diagram form, the voltage and current functions used in association with the 5 oxidation process according to Figure 9, and Figure 10 shows, in table form, parameters of the titanium oxide layer. DETAILED EMBODIMENT 10 In accordance with what has been described above, the present invention proposes, inter alia, a method by which it is possible to establish a high oxide porosity and oxide thickness on a titanium implant in order to function as a support for a 15 substance which initiates, stimulates and increases the rate at which the implant incorporates in the bone material in question in the human body. The invention is based on the recognition that the rate at which bone forms can to a large extent be influenced by growth 20 factors which are produced using, for example, TGF-3 and other bone matrix proteins. The invention aims, inter alia, to deliver and release such substances in a controlled manner to the bone surrounding the metal implant. The oxide layer has a high degree of porosity. 25 The pore volumes function as depots for the substances. The relatively large surface area of the pore walls is used to immobilize the substances through adsorption. According to the invention, the implant surface is made of a highly porous titanium oxide which itself has 30 positive properties in respect of incorporation. In order to control the rate of release of the active substances, the present invention proposes that the pore density (i.e. the number of pores per surface unit) and the pore geometry (diameter and depth) are 35 varied in a controlled manner. Among other things, the present invention concerns a surface layer on a titanium implant which is designed so that its properties themselves have a positive effect on bone incorporation around the WO 00/72777 PCT/SEOO/01027 - 13 implant and in addition have the function of constituting a support for an effective substrate which is delivered in a controlled manner to the implant surface in order then to release biologically active 5 substances which accelerate the formation of bone around the implant. The surface consists of an oxide layer which largely comprises TiO 2 and has a surface roughness Ra preferably in the range of 1 - 5 pm (for example 4 gm) or less. In addition, the oxide layer 10 will have a thickness which, in one embodiment, can be varied within a range of 1 - 20 pm. In exceptional cases, it will be possible to use values of as little as 0.5 pm. The oxide layer will also be highly porous, with a large number of open pores per surface unit, and 15 with pore diameters which can be varied in the range of 0.01 - 10 pzm. In a preferred embodiment, the oxide layer has a thickness in the range of 2 - 20 pn. In a further embodiment, the oxide layer has a surface roughness in the range of 0. 4 - 5 pm. In the said 20 preferred embodiment, the oxide layer is highly porous, with 1 x 107 - 1 x 10" pores/cm 2 . The implant in the preferred embodiment will also have pores with diameter sizes in the range of 0.1 - 10 pm. The pore volume is chosen in accordance with the above. This arrangement 25 will be able to be combined with pores which have different characteristics, smaller diameters, more or less closed configurations, and different depths. The resulting porous oxide layer gives rise to two main effects in implant applications in bone. First, the 30 properties of the surface themselves may be expected to result in accelerated incorporation of bone and anchoring of the implant by means of the preferred combination of surface roughness, pore volume, porosity and oxide thickness. In addition, as a second effect, 35 the surface layer can function as a suitable means of immobilizing controlled quantities of biologically active substances which act on the growth process in the bone. The surface layer thus functions as a support for the substance in question. The immobilization can WO 00/72777 PCT/SEO0/01027 - 14 be effected in principle in different ways, the first being achieved by spontaneous adsorption of molecules in the solution in question onto the surfaces of the pore walls. In a second embodiment, use is made of the 5 fact that the substances in question have a net charge different from zero, which means that adsorption from solution onto the surfaces of the pore walls can be accelerated by means of an electrical field which has been applied by applying a suitable voltage to the 10 sample in a cell. A third way is to press the substances into the pores by pressure, the substance in question being given a suitable viscosity. A fourth way to apply substance is to use a gel support for the substance. The gel support with the substance is 15 applied on or pressed against the porous oxide layer. The gel support is of a highly viscous type. The release or the release function for the substance into the tissue will depend on the geometric configurations of the pores. By controlling the pore geometries or the 20 pore characteristics, different rates of release can be obtained. By different combinations of smaller and larger pores, the release can be programmed to follow a desired sequence over the course of time. This is due to the fact that a high rate of release is obtained in 25 the initial stage from larger pores, and this is followed by slow or slower release, for a longer period of time, from small and/or deep pores. In Figure 1, reference number 1 indicates parts of a jaw bone in which a hole 2 has been formed. An 30 implant 3 has been screwed into the hole 2 via its threads 3a. The said threads produce a corresponding thread formation la in the jaw bone as the implant is screwed into the hole. Alternatively, the hole can be pre-threaded. 35 Figure la shows the surface character of a thread 3a' on a very greatly enlarged scale (for the sake of clarity) . Reference numbers 4 and 5 indicate oxide layers on surfaces 6 and 7 of the thread part 3a'. The thread or threads is/are turned or milled WO 00/72777 PCT/SEOO/01027 - 15 and, if appropriate, polished or subjected to another form of machining. The implant 3, 3a' in the present case is assumed to be made of titanium, and the said layers 4 and 5 are titanium oxide layers which are 5 produced in the manner described below. Figure la shows a first area 8 of the surface 7. The area in question can comprise pores with different pore sizes, pore depths, etc., in accordance with what has been described above. Figure la also shows a second partial 10 enlargement 9 of the surface 6. The different areas 9a and 9b of area 9 can be provided with different pore characters. In Figure lb, reference number 10 indicates a container for substance 11 in accordance with what has 15 been described above. In the container, parts of the surface 6' and the titanium oxide layer 4' are shown immersed in the substance 11. Upon immersion in the substance 11, substance penetrates into the porous layer 4' which thereafter, when the implant is removed 20 from the container, functions as a depot or store for the substance which has thus penetrated into it. The immersion or adsorption time is chosen as a function of the configuration of the porous layer. In one embodiment, the layer 4' will, for example, be immersed 25 in the substance for 1 hour (see also description below). Figure 2 shows different controlled release functions with curves 12, 13 and 14. The curve 12 shows a first release function during a time period which can 30 be chosen to last 1 to 2 weeks. Other courses for the release function can be chosen, as shown by the curves 13 and 14, where the curve 13 decreases more than the curve 12, and where the curve 14 shows an initially powerful release function which decreases relatively 35 quickly. The choice of release function or curve shape can be chosen on the basis of experience of the bone growth process. The first curve shows a relatively slowly decreasing release function.
WO 00/72777 PCT/SEOO/01027 - 16 Figures 3 and 4 show different titanium oxide layer structures 4'' and 4'''. In the structure 4'', the surface has diffraction peaks deriving from the crystal structure for rutile and underlying titanium. 5 The structure 4''' according to Figure 4 has diffraction peaks from the crystal structure for a mixture of anatase, rutile and underlying titanium. The oxide layers according to Figures 3 and 4 have somewhat different relative concentrations. Thus, the surface of 10 the oxide layer according to Figure 3 has a composition of 21.1% Ti, 55.6% and 20.6% C. In addition, there are small amounts of S (0.8%), N (1.4%) and P (0.6%). The composition of the oxide layer according to Figure 4 is 21.3%, 56.0% and 20.5% respectively (and 0.8%, 0.7% and 15 0.6% respectively) . The number of pores in the oxide layers shown can be in the range of 187. 6 x 106. A total pore volume or porosity can be chosen at around 21.7 x 10-5 cm3 . The oxide layers can be saturated in substance, with saturation times of up to 48 hours, for 20 example. Figure 5 is intended to show, at 15, the pore diameters used in the titanium oxide layer according to Figure 3. This shows the number of pores with diameters in the range of 0.1 - 0.8 tm. 25 Figures 6 and 7 show different embodiments of pore characteristics or pore structures 16 and 17. The titanium oxide layers according to the above are preferably produced by so-called anodic oxidation, which is an electrochemical process. The 30 principle and procedure for obtaining the layers in question are described with reference to Figures 8 and 9. In Figure 8, a container is indicated by 18. A titanium anode is indicated by 19, and a porous meshed cathode is shown by- 20. A Teflon insulation for the 35 titanium anode is shown by 21, and the anodes extend through a Teflon cover 22. A magnetic agitator 23 is also included. The connections for the anode and the cathode are indicated by 19' and 20', respectively. The implant or the parts of the implant to be prepared WO 00/72777 PCT/SEOO/01027 - 17 is/are preferably mechanically worked by turning, milling, polishing, etc. The implant or the parts in question comprise(s) titanium surfaces which are to be treated in the electrochemical process. The implant or 5 the parts in question is/are mounted on a holder which is immersed in a bath of electrolyte 24 in the container. The parts of the implant which are not to be treated are masked with a liquid-tight protective cover or alternatively with a suitable lacquer which is 10 applied on those parts in question which are not to be treated. The implant or its said parts is/are in electrical contact, via the holder, with the connection 19 above the electrolyte surface. In the electrolyte, the said cathode 20 serves as a counter-electrode. This 15 counter-electrode is made of a suitable material, for example Pt, gold or graphite. The counter-electrode is preferably mounted on the holder in such a way that the whole arrangement is jointly fixed in the electrolyte bath 24. The anodic oxidation is effected by applying 20 an electrical voltage between the implant/implant part/implant parts and the counter-electrode, whereupon the implant or its part or parts in question is/are given a positive potential. The implant, the implant part/implant parts, the counter-electrode and the 25 electrolyte constitute an electrochemical cell in which the implant or its respective part forms an anode. The difference in electrical potential between implant/ implant part and counter-electrode gives rise to a current of negatively (positively) charged electrolyte 30 ions to the implant/implant part (counter-electrode) . If suitable electrolyte has been chosen, the electrode reactions in the cell result in oxide layers forming on the surface of the implant or implant part. As the electrode reactions also result in gas formation, the 35 electrolyte should be stirred in a suitable manner, which is done using the said magnetic agitator 23 which prevents gas bubbles from remaining on the electrode surfaces.
WO 00/72777 PCT/SEOO/01027 - 18 The formation of the titanium oxide layer and its final properties are influenced by a number of parameters in the process, for example the electrolyte composition and temperature, the applied voltage and 5 current, the electrode geometry, and the treatment time. The way in which the desired layers are produced is described in more detail below. Examples are also given of how the process parameters affect various properties of the oxide layers and how oxide thickness 10 and porosity can be varied. The desired layer properties are achieved starting out from mechanically worked surface, which can be turned or polished. The surface is cleaned in a suitable manner, for example by ultrasound cleaning in 15 organic solvents in order to remove impurities from previous production stages. The cleaned implant or the cleaned implant part is secured in the said container, which is secured together with the counter-electrode on the holder. The arrangement can then be lowered into 20 the electrolyte. The two electrodes are then coupled to a voltage source (not shown) and an electrical voltage is applied, whereupon the process starts. The process is ended after the desired time by interrupting the voltage supply. 25 The electrical voltage can be applied in different ways, cf. also Figure 10. In a galvanostatic process, the current is kept constant, and the voltage is allowed to vary according to the resistance in the cell, whereas, in a potentiostatic process, the voltage 30 is kept constant and the current is allowed to vary. The desired layers are preferably formed using a combination of galvanostatic and potentiostatic control. Galvanostatic control is used in a first stage, the voltage being allowed to increase to a 35 preset value. When this voltage value is reached, the process changes over to potentiostatic control. On account of the resistance of the oxide layer which has formed, the current drops in this state.
WO 00/72777 PCT/SE0O/01027 - 19 Figure 9 shows the development of current 25 and voltage 26 over the course of time. The exact appearance of the curves depends on various process parameters and also reflects the formation of the oxide 5 layer and its properties. Up to a certain voltage, which is dependent on electrolyte, relatively thin (< 0.2 jm) oxide layers are obtained, the oxide layer thickness being approximately linearly dependent on the applied 10 voltage, independently of the treatment time after the maximum voltage has been reached. These layers are essentially closed, and only in exceptional cases do they have a partially open porosity. For most electrolytes, the critical voltage is around 100 volts. 15 To achieve the desired porous oxide layers, much higher voltages need to be applied, typically of 150 to 400 volts, depending on the electrolyte. At these voltages, the oxide thickness is no longer linearly dependent on the voltage, and much thicker 20 layers can be produced. For certain electrolytes, the oxide thickness at these voltages is also dependent on the treatment time after the maximum voltage has been reached. Suitable electrolytes for achieving porous layers by this method are diluted inorganic acids (for 25 example sulphuric acid, phosphoric acid, chromic acid), and/or diluted organic acids (for example acetic acid, citric acid) or mixtures of these. Figures 6 and 7 show examples of porous oxide layers produced according to the above method, at 200 30 volts in 0.35 molar sulphuric acid and, respectively, 300 volts in 0.25 molar phosphoric acid. The implant which has been treated in sulphuric acid has a surface with a high density of open pores. Some 20% of the surface consists of pores, with sizes 35 (diameters) preferably in the range of 0.1 - 0.5 pm. The thickness of the layer is 2 pm. The implant which has been treated in phosphoric acid has a similar pore density. The pore size distribution can differ considerably. Pore sizes can be chosen preferably in WO 00/72777 PCT/SEOO/01027 - 20 the range of 0.3 - 0.5 pm, but a good number of larger pores (up to 1.5 pm) can also be present on the surface. The oxide thickness of this sample is 5 pim. The implant surface in question can additionally or 5 alternatively be pretreated chemically, for example with hydrogen fluoride (HF). The table in Figure 10 shows the structures of oxide layers made using different process parameters. The invention is not limited to the embodiment 10 described above by way of example, and instead can be modified within the scope of the attached patent claims and the inventive concept.
Claims (28)
1. Implant comprising or consisting of titanium 5 and having one or more surfaces which can be applied in or on tissue areas and/or bone growth areas, one or more of the said surfaces being arranged with a depot for bone-growth-initiating or bone-growth-stimulating substance, which depot is formed by a pore arrangement 10 in a relatively thick oxide layer on the titanium, characterized in that the substance, for a period of time, is acted on by, or works with, one or more release functions which permit a preferably essentially controlled release of substance to the respective 15 surrounding tissue or tissue/bone growth areas.
2. Implant according to Patent Claim 1, characterized in that two or more release arrangements are obtained by means of different pore arrangements within one or more areas of one or more of the said 20 surfaces.
3. Implant according to Patent Claim 1 or 2, characterized in that pores with different pore characteristics, for example open or more or less closed pores, pore depth, pore density, pore volume, 25 etc., are arranged within one or more areas.
4. Implant according to Patent Claim 1, 2 or 3, characterized in that the release function(s) operate(s) with combinations of larger and smaller pores arranged to effect a desired release sequence 30 over time.
5. Implant according to Patent Claim 4, characterized in that larger pores effect a more rapid release, and smaller and/or deep pores effect a delayed release. 35
6. Implant according to any of the preceding claims, characterized in that different areas are provided with different pore characteristics.
7. Implant according to any of the preceding patent claims, characterized in that the surface of the WO 00/72777 PCT/SEO0/01027 - 22 oxide layer comprises about 20% titanium, about 55% oxygen and about 20% carbon, and the layer otherwise consists of titanium dioxide.
8. Implant according to any of the preceding 5 patent claims, characterized in that the oxide layer has a surface roughness of about 1 - 5 Pim or less.
9. Implant according to any of the preceding patent claims, characterized in that the oxide layer has a thickness in the range of 1 - 20 pin, preferably 10 2 - 20 pm.
10. Implant according to any of the preceding patent claims, characterized in that the oxide layer is highly porous, with pore diameters in the range of 0.01 - 10 Pm. 15
11. Implant for application in a hole formed in tissue and/or bone, for example the jaw bone, characterized in that it comprises a titanium portion which can cooperate with the hole formation, in that the titanium portion is designed with one or more very 20 thick titanium oxide layers having surfaces which can be placed against the tissue and/or bone in the hole formation, in that each oxide layer is provided with a pore arrangement which functions as a depot for bone growth-initiating and/or bone-growth-stimulating 25 substance, for example a substance belonging to the superfamily TGF-S, and in that, when the depot is filled with substance and the implant is in position in the hole, a release function for releasing the substance to the bone comes into operation. 30
12. Implant according to Patent Claim 11, characterized in that the release function is controlled, for a chosen period of time.
13. Implant according to Patent Claim 12, characterized in that the release function is 35 controlled by the choice of pore arrangement and pore characteristics in or on the said layer.
14. Implant according to any of Patent Claims 9 to 13, characterized in that the oxide layer is highly porous. WO 00/72777 PCT/SEOO/01027 - 23
15. Implant according to any of Patent Claims 9 to 14, characterized in that it is a screw implant which bears the said oxide layers and surfaces on its threads. 5
16. Method for producing an implant intended to be applied in or at a hole formed in tissue and/or bone, preferably the jaw bone, characterized in that the implant is produced, for example by means of machining, with a portion of titanium which has surfaces which can 10 be placed against the bone and/or tissue when the implant is in position in the hole, in that the said titanium on the said surface or surfaces is subjected to anodic oxidation to an extent which gives a highly porous and relatively thick oxide layer on each surface 15 concerned, in that bone-growth-initiating substance or bone-growth-stimulating substance, for example a substance belonging to the superfamily TGF-$, is applied to the said porous and thick layers, for example by saturation or immersion, and in that the 20 implant is placed in its position in the hole, resulting in the process of release of the substance to the bone being started by the release of components in the tissue and/or bone.
17. Method according to Patent Claim 16, 25 characterized in that the implant, at the part or parts bearing the said surfaces, is provided with one or more threads, and in that the implant is screwed into the bone.
18. Method according to Patent Claim 16 or 17, 30 characterized in that the oxide layer is immersed in a container holding the substance.
19. Use of a highly porous and thick titanium oxide layer to which bone-growth-initiating and bone-growth stimulating substance has been added, for example a 35 substance belonging to the superfamily TGF-0, characterized in that it is used on implants which can be inserted into holes in tissue and/or bone, preferably the jaw bone. WO 00/72777 PCT/SEOO/01027 - 24
20. Use according to Patent Claim 19, characterized in that it is used on the thread or threads of the implant and/or on the area above the thread or threads.
21. Use according to Patent Claim 19 or 20, 5 characterized in that it is used in holes involving soft and/or reduced bone.
22. Implant comprising or consisting of titanium and having one or more surfaces which can be applied in or on tissue areas and/or bone growth areas, one or 10 more of the said surfaces being arranged with a depot for bone-growth-initiating or bone-growth-stimulating substance, for example a substance belonging to the superfamily TGF-, which depot is formed by a pore arrangement in a relatively thick oxide layer on the 15 titanium, characterized in that the oxide layer has a thickness in the range of 1 - 20 pim, for example 2 - 20 pm.
23. Implant according to Patent Claim 22, characterized in that the oxide layer has a surface 20 roughness in a range of 0.4 - 5 pm.
24. Implant according to Patent Claim 22 or 23, characterized in that the oxide layer is highly porous, with 1 x 10' - 1 x 10" pores/cm 2 .
25. Implant according to Patent Claim 22, 23 or 24, 25 characterized in that each surface essentially has pores with diameter sizes in the range of 0.1 - 10 pm, and/or in that the total pore volume is within a range of 5 x 10-2 and 10-5 cm 3 .
26. Method for producing, on an implant comprising 30 or consisting of titanium, and by means of anodic oxidation, relatively thick oxide layers on one or more titanium surfaces which are intended to be placed against or arranged adjacent to one or more tissue and/or bone growth areas, in which method at least the 35 part or parts bearing the said surface or surfaces are prepared and immersed in electrolyte and the implant is brought into contact with an electrical energy source above the electrolyte surface, and the oxidation process is established by also connecting to the energy WO 00/72777 PCT/SEOO/01027 - 25 source a counter-electrode which is arranged in the electrolyte, characterized in that diluted inorganic acids, diluted organic acids and/or small quantities of hydrofluoric acid or hydrogen peroxide are added to the 5 electrolytic composition, and in that the energy source is chosen to operate at a voltage value or voltage values in the range of 150 - 400 volts.
27. Method according to Patent Claim 26, characterized in that the voltage is varied for the 10 same implant at different times in order to create different pore sizes within the same surface areas.
28. Method according to Patent Claim 26 or 27, characterized in that the position of the implant in the electrolyte is changed, together with the 15 composition of the electrolyte and/or the voltage, in order to create different oxide thicknesses and/or areas with different porosity or pore characteristics.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901971 | 1999-05-31 | ||
SE9901971A SE514323C2 (en) | 1999-05-31 | 1999-05-31 | Implants and procedure and use in implants |
PCT/SE2000/001027 WO2000072777A1 (en) | 1999-05-31 | 2000-05-23 | Implant, method for producing the implant, and use of the implant |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5260900A true AU5260900A (en) | 2000-12-18 |
AU779521B2 AU779521B2 (en) | 2005-01-27 |
Family
ID=20415799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52609/00A Ceased AU779521B2 (en) | 1999-05-31 | 2000-05-23 | Implant, method for producing the implant, and use of the implant |
Country Status (10)
Country | Link |
---|---|
US (2) | US7708558B1 (en) |
EP (1) | EP1196110B1 (en) |
JP (1) | JP4237418B2 (en) |
AT (1) | ATE419804T1 (en) |
AU (1) | AU779521B2 (en) |
CA (1) | CA2373934C (en) |
DE (1) | DE60041332D1 (en) |
ES (1) | ES2320723T3 (en) |
SE (1) | SE514323C2 (en) |
WO (1) | WO2000072777A1 (en) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE514323C2 (en) | 1999-05-31 | 2001-02-12 | Nobel Biocare Ab | Implants and procedure and use in implants |
US6610067B2 (en) | 2000-05-01 | 2003-08-26 | Arthrosurface, Incorporated | System and method for joint resurface repair |
US6520964B2 (en) | 2000-05-01 | 2003-02-18 | Std Manufacturing, Inc. | System and method for joint resurface repair |
US7163541B2 (en) * | 2002-12-03 | 2007-01-16 | Arthrosurface Incorporated | Tibial resurfacing system |
US8177841B2 (en) | 2000-05-01 | 2012-05-15 | Arthrosurface Inc. | System and method for joint resurface repair |
US7678151B2 (en) * | 2000-05-01 | 2010-03-16 | Ek Steven W | System and method for joint resurface repair |
US7896883B2 (en) | 2000-05-01 | 2011-03-01 | Arthrosurface, Inc. | Bone resurfacing system and method |
SE0004854D0 (en) † | 2000-12-22 | 2000-12-22 | Haakan Nygren | Surface modification of implants for bone and soft tissue healing |
WO2002087648A1 (en) * | 2001-04-27 | 2002-11-07 | Vivoxid Oy | Method for improvement of soft tissue attachment and implants making use of said method |
US7291178B2 (en) | 2001-05-29 | 2007-11-06 | Mediteam Dental Ab | Modified oxide |
SE0101910D0 (en) * | 2001-05-29 | 2001-05-29 | Young Taeg Sul | Modified oxide |
SE519566C2 (en) * | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Method of Treating Implants by Coating with Calcium Phosphate and Bone Growth Stimulants |
SE519531C2 (en) * | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Implants including pore arrangements coated with calcium phosphate |
SE519565C2 (en) * | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Arrangement and method of providing implant fixtures made primarily of titanium |
SE519564C2 (en) * | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Implants, for example dental implants, coated with bone growth stimulants |
GB0116725D0 (en) * | 2001-07-09 | 2001-08-29 | Europ Economic Community | Biomedical titanium implants |
CN100425285C (en) | 2001-11-19 | 2008-10-15 | Scil技术股份有限公司 | Device having osteoinductive and osteoconductive properties |
SE523395C2 (en) * | 2001-12-21 | 2004-04-13 | Nobel Biocare Ab | Implants and methods and systems for providing such implants |
SE520756C2 (en) | 2001-12-21 | 2003-08-19 | Nobel Biocare Ab | Method of providing surface structure on implants as well as such implants |
CH695985A5 (en) * | 2002-01-21 | 2006-11-15 | Straumann Holding Ag | Surface-modified implants. |
DE10206627A1 (en) * | 2002-02-15 | 2003-08-28 | Diocom B V | Titanium implant replacing body joint with one or more base bodies |
US7410502B2 (en) | 2002-04-09 | 2008-08-12 | Numat As | Medical prosthetic devices having improved biocompatibility |
EP1492579B1 (en) * | 2002-04-09 | 2008-09-10 | Numat AS | Medical prosthetic devices having improved biocompatibility |
GB0208642D0 (en) | 2002-04-16 | 2002-05-22 | Accentus Plc | Metal implants |
SE522981C2 (en) * | 2002-07-01 | 2004-03-23 | Nobel Biocare Ab | Device and method for maintaining neoplastic effect of growth-stimulating substances in implant product |
SE522983C2 (en) | 2002-07-25 | 2004-03-23 | Nobel Biocare Ab | Arrangements to increase the resistance to load on implants and such implants |
SE522984C2 (en) * | 2002-07-25 | 2004-03-23 | Nobel Biocare Ab | Device for two or more implants provided with growth-stimulating substance (s) |
SE523011C2 (en) * | 2002-07-25 | 2004-03-23 | Nobel Biocare Ab | Device for implants carrying growth-stimulating substance or substances and such implant |
SE523024C2 (en) * | 2002-07-25 | 2004-03-23 | Nobel Biocare Ab | Device for inducing bone by bone inductive or bioactive agent and / or increasing the stability of jaw bone implants and implants therefor |
SE523012C2 (en) * | 2002-07-25 | 2004-03-23 | Nobel Biocare Ab | Device for building bone-based lateral support for implants in the jawbone by means of bioactive or bone inductive material |
US7763270B2 (en) | 2002-09-10 | 2010-07-27 | Scil Technology Gmbh | Metal implant coated under reduced oxygen concentration with osteoinductive protein |
US7901408B2 (en) | 2002-12-03 | 2011-03-08 | Arthrosurface, Inc. | System and method for retrograde procedure |
SE526667C2 (en) * | 2002-12-30 | 2005-10-25 | Nobel Biocare Ab | Device for implants and method for making the implant |
US8388624B2 (en) | 2003-02-24 | 2013-03-05 | Arthrosurface Incorporated | Trochlear resurfacing system and method |
IL156033A0 (en) | 2003-05-21 | 2004-03-28 | Ophir Fromovich Ophir Fromovic | Dental implant |
EP1684642A4 (en) | 2003-11-20 | 2008-12-03 | Arthrosurface Inc | Retrograde delivery of resurfacing devices |
AU2006203909A1 (en) | 2003-11-20 | 2006-07-13 | Arthrosurface, Inc. | System and method for retrograde procedure |
SE527019C2 (en) * | 2003-12-11 | 2005-12-06 | Nobel Biocare Ab | Implant for application in the jawbone |
SE526749C2 (en) | 2003-12-11 | 2005-11-01 | Nobel Biocare Ab | Dental implant device and method for its preparation |
ATE482667T1 (en) * | 2004-03-04 | 2010-10-15 | Young-Taek Sul | OSSEOINDUCTIVE MAGNESIUM-TITANIUM IMPLANT AND PRODUCTION METHOD THEREOF |
WO2005089829A2 (en) | 2004-03-10 | 2005-09-29 | Scil Technology Gmbh | Coated implants, their manufacturing and use thereof |
GB0405680D0 (en) * | 2004-03-13 | 2004-04-21 | Accentus Plc | Metal implants |
CA2572584A1 (en) | 2004-06-28 | 2006-01-12 | Arthrosurface, Inc. | System for articular surface replacement |
US8329202B2 (en) | 2004-11-12 | 2012-12-11 | Depuy Products, Inc. | System and method for attaching soft tissue to an implant |
US7828853B2 (en) | 2004-11-22 | 2010-11-09 | Arthrosurface, Inc. | Articular surface implant and delivery system |
US9327056B2 (en) | 2006-02-14 | 2016-05-03 | Washington State University | Bone replacement materials |
US9028871B2 (en) | 2006-04-25 | 2015-05-12 | Washington State University | Resorbable ceramics with controlled strength loss rates |
US8916198B2 (en) | 2006-04-25 | 2014-12-23 | Washington State University | Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
DK2026852T3 (en) * | 2006-06-12 | 2011-04-04 | Accentus Medical Plc | metal Implants |
US20110213375A1 (en) | 2006-07-17 | 2011-09-01 | Arthrosurface, Inc. | Tibial Resurfacing System and Method |
DE102006052552A1 (en) * | 2006-11-06 | 2008-05-08 | Auriga Medical Products Gmbh | Coated dental implant |
EP2136717B1 (en) | 2006-12-11 | 2013-10-16 | Arthrosurface Incorporated | Retrograde resection apparatus |
US8038442B2 (en) | 2007-04-23 | 2011-10-18 | Nobel Biocare Services Ag | Dental implant and dental component connection |
EP2014319A1 (en) | 2007-07-09 | 2009-01-14 | Astra Tech AB | A bone tissue implant comprising strontium ions |
EP2014259A1 (en) | 2007-07-09 | 2009-01-14 | Astra Tech AB | A bone tissue implant comprising lithium ions |
DE102007044159A1 (en) * | 2007-09-11 | 2009-03-12 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Metal materials with hybrid-stabilized oxide layer, process for the preparation and their use |
US8858775B2 (en) | 2007-10-03 | 2014-10-14 | Accentus Medical Limited | Method of manufacturing metal with biocidal properties |
EP2143451A1 (en) * | 2008-07-11 | 2010-01-13 | Nobel Biocare Services AG | Bone implant application |
DE112010000680T5 (en) * | 2009-02-23 | 2012-12-13 | Arthrosurface, Inc. | Nanoroutly alloy substrate |
WO2016154393A1 (en) | 2009-04-17 | 2016-09-29 | Arthrosurface Incorporated | Glenoid repair system and methods of use thereof |
CA2759027C (en) | 2009-04-17 | 2020-02-25 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
US9662126B2 (en) | 2009-04-17 | 2017-05-30 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
SE0950972A1 (en) * | 2009-12-17 | 2011-06-18 | Tigran Technologies Ab Publ | Porous block of titanium or titanium alloy |
TWI480026B (en) * | 2010-01-14 | 2015-04-11 | Univ Nat Taipei Technology | Bio-implant having screw body selectively formed with nanoporous in spiral groove and method of making the same |
ES2363021B1 (en) * | 2010-12-27 | 2012-02-24 | Terrats Mecanizados, S.L. | IMPROVED PROTESTIC ADDITION. |
RU2521598C2 (en) * | 2011-01-13 | 2014-07-10 | Общество с ограниченной ответственностью "МЕДЭЛ" | Method of electret production |
JP2012143416A (en) | 2011-01-13 | 2012-08-02 | Gc Corp | Dental implant and surface treatment method of dental implant |
TW201231021A (en) * | 2011-01-27 | 2012-08-01 | Univ Nat Chiao Tung | Artificial root with nanostructure |
ITPD20110022A1 (en) * | 2011-01-28 | 2012-07-29 | Eugenio Conte | ORTHODONTIC PLANT WITH TREATED CONTACT BONE SURFACE |
TW201238570A (en) * | 2011-03-22 | 2012-10-01 | Riemser Arzneimittel Ag | Dental implant having a first conical screw part and a second cylindrical screw part |
US9066716B2 (en) | 2011-03-30 | 2015-06-30 | Arthrosurface Incorporated | Suture coil and suture sheath for tissue repair |
WO2012170136A1 (en) * | 2011-06-09 | 2012-12-13 | Synthes Usa, Llc | Anodizing container |
WO2013096746A1 (en) | 2011-12-22 | 2013-06-27 | Arthrosurface Incorporated | System and method for bone fixation |
US9468448B2 (en) | 2012-07-03 | 2016-10-18 | Arthrosurface Incorporated | System and method for joint resurfacing and repair |
US9492200B2 (en) | 2013-04-16 | 2016-11-15 | Arthrosurface Incorporated | Suture system and method |
CN103536371B (en) * | 2013-10-21 | 2016-03-23 | 中国科学院上海硅酸盐研究所 | A kind of dentistry implant and preparation method thereof |
US10624748B2 (en) | 2014-03-07 | 2020-04-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
GB2523828A (en) | 2014-03-07 | 2015-09-09 | Nobel Biocare Services Ag | Dental implant |
GB2523827A (en) | 2014-03-07 | 2015-09-09 | Nobel Biocare Services Ag | Dental implant |
US11607319B2 (en) | 2014-03-07 | 2023-03-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
GB2523814A (en) * | 2014-03-07 | 2015-09-09 | Nobel Biocare Services Ag | Implant surface composition |
US9861492B2 (en) | 2014-03-07 | 2018-01-09 | Arthrosurface Incorporated | Anchor for an implant assembly |
JP2015229792A (en) * | 2014-06-05 | 2015-12-21 | オリンパス株式会社 | Implant and production method thereof |
EP3034033A1 (en) | 2014-12-16 | 2016-06-22 | Nobel Biocare Services AG | Dental implant |
CN105395263A (en) * | 2015-11-20 | 2016-03-16 | 吴大怡 | Combined-type soft tissue horizontal dental implant |
CN105963032A (en) * | 2016-04-22 | 2016-09-28 | 吴大怡 | Pinhole bone extruding and expanding apparatus |
EP3391915B1 (en) | 2017-03-30 | 2021-04-14 | Biomet Manufacturing, LLC | Methods of modifying the porous surface of implants |
US11246807B2 (en) | 2017-07-07 | 2022-02-15 | Armis Biopharma, Inc. | Oxidative compositions and methods for stimulating the growth of osteoblasts and use in dental coatings and jaw bone augmentation |
WO2019028344A1 (en) | 2017-08-04 | 2019-02-07 | Arthrosurface Incorporated | Multicomponent articular surface implant |
US20210308333A1 (en) * | 2018-06-17 | 2021-10-07 | University Health Network | Compounds and devices having topographical complex surface for wound healing |
AU2019379758A1 (en) | 2018-11-12 | 2021-06-10 | Nobel Biocare Services Ag | Dental implant, component for dental applications, implant system for dental applications, method for forming a protective layer on the surface of an implantable or implant component, implantable or implant component having a protective layer, and use of a protective layer |
GB2596006B (en) | 2019-03-12 | 2022-11-30 | Arthrosurface Inc | Humeral and glenoid articular surface implant systems and methods |
EP4017030A1 (en) | 2020-12-18 | 2022-06-22 | CADskills | Device for coupling a bone conduction vibrator |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416175B (en) * | 1979-03-07 | 1980-12-08 | Per Ingvar Branemark | FOR IMPLANTATION IN BODY TISSUE Separate Bone Tissue, Dedicated Material |
US4542539A (en) | 1982-03-12 | 1985-09-24 | Artech Corp. | Surgical implant having a graded porous coating |
US4655776A (en) * | 1984-01-12 | 1987-04-07 | Oto Enterprises, Inc. | Prostheses for ossicular reconstruction |
CA1269898A (en) * | 1986-10-17 | 1990-06-05 | Takayuki Shimamune | Process for production of calcium phosphate compound- coated composite material |
US5164187A (en) | 1990-04-05 | 1992-11-17 | Norian Corporation | Hydroxyapatite prosthesis coatings |
US5213742A (en) | 1990-09-11 | 1993-05-25 | Vitaphore Corporation | Method of producing pores of controlled geometry on a thermoplastic polymer |
DE59209889D1 (en) * | 1991-09-13 | 2001-03-01 | David J Baylink | BONE GROWTH-PROMOTING COMPOSITION |
SE469653B (en) * | 1992-01-13 | 1993-08-16 | Lucocer Ab | POROEST IMPLANT |
HU213001B (en) * | 1992-04-10 | 1997-01-28 | Tavkoezlesi Innovacios Rt | Process for obtaining tissue-protective deposit on implants prepared from titanium and/or titanium-base microalloy |
US5447550A (en) * | 1994-09-21 | 1995-09-05 | Hylsa S.A. De C.V. | Method and apparatus for the pneumatic transport of iron-bearing particles |
US5843289A (en) * | 1996-01-22 | 1998-12-01 | Etex Corporation | Surface modification of medical implants |
DE69825570T2 (en) * | 1997-03-27 | 2005-09-15 | Smith & Nephew, Inc., Memphis | METHOD FOR THE PRODUCTION OF OXIDES WITH CONSTANT THICKNESS ON CIRCONIUM ALLOYS |
SE9701647D0 (en) | 1997-04-30 | 1997-04-30 | Nobel Biocare Ab | Calcium-phonsphate coated implant element |
SE513481C2 (en) * | 1997-05-16 | 2000-09-18 | Nobel Biocare Ab | Implant element made of titanium with a titanium oxide surface modified by eloxidation |
US20050031663A1 (en) * | 1997-05-16 | 2005-02-10 | Cecilia Larsson | Implant element |
SE513556C2 (en) * | 1997-11-11 | 2000-10-02 | Nobel Biocare Ab | Implant element with thin surface applied by hot isostatic pressing |
SE515695C2 (en) * | 1999-05-31 | 2001-09-24 | Nobel Biocare Ab | Implant with coating of bone growth stimulant for bone application and procedure in such implant |
SE514323C2 (en) * | 1999-05-31 | 2001-02-12 | Nobel Biocare Ab | Implants and procedure and use in implants |
US7048541B2 (en) * | 2000-04-04 | 2006-05-23 | Nobel Biocare Ab | Implant having attachment and hole-insert parts, and method for producing such an implant |
-
1999
- 1999-05-31 SE SE9901971A patent/SE514323C2/en not_active IP Right Cessation
-
2000
- 2000-05-23 US US09/980,011 patent/US7708558B1/en not_active Expired - Fee Related
- 2000-05-23 AU AU52609/00A patent/AU779521B2/en not_active Ceased
- 2000-05-23 ES ES00937436T patent/ES2320723T3/en not_active Expired - Lifetime
- 2000-05-23 CA CA2373934A patent/CA2373934C/en not_active Expired - Fee Related
- 2000-05-23 AT AT00937436T patent/ATE419804T1/en active
- 2000-05-23 EP EP00937436A patent/EP1196110B1/en not_active Expired - Lifetime
- 2000-05-23 DE DE60041332T patent/DE60041332D1/en not_active Expired - Lifetime
- 2000-05-23 JP JP2000620891A patent/JP4237418B2/en not_active Expired - Fee Related
- 2000-05-23 WO PCT/SE2000/001027 patent/WO2000072777A1/en active IP Right Grant
-
2010
- 2010-01-08 US US12/684,591 patent/US8349009B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1196110B1 (en) | 2009-01-07 |
US7708558B1 (en) | 2010-05-04 |
EP1196110A1 (en) | 2002-04-17 |
JP2003500160A (en) | 2003-01-07 |
SE514323C2 (en) | 2001-02-12 |
DE60041332D1 (en) | 2009-02-26 |
JP4237418B2 (en) | 2009-03-11 |
WO2000072777A1 (en) | 2000-12-07 |
US20100112519A1 (en) | 2010-05-06 |
CA2373934A1 (en) | 2000-12-07 |
AU779521B2 (en) | 2005-01-27 |
SE9901971L (en) | 2000-12-01 |
SE9901971D0 (en) | 1999-05-31 |
ATE419804T1 (en) | 2009-01-15 |
CA2373934C (en) | 2010-06-22 |
ES2320723T3 (en) | 2009-05-28 |
US8349009B2 (en) | 2013-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2373934C (en) | Titanium implant comprising a porous oxide surface layer acting as a depot for bone-growth-initiating or bone-growth-stimulating substances | |
US8152856B2 (en) | Layer arranged on implant for bone or tissue structure, such an implant, and a method for application of the layer | |
Alla et al. | Surface roughness of implants: a review | |
US5478237A (en) | Implant and method of making the same | |
US4846837A (en) | Ceramic-coated metal implants | |
CN101871118B (en) | Method for preparing titanium dioxide layer with multi-level pore structure on surface of medicinal titanium | |
Kim et al. | Electrochemical surface modification of titanium in dentistry | |
Li et al. | Bridging the gap: Optimized fabrication of robust titania nanostructures on complex implant geometries towards clinical translation | |
TWI480026B (en) | Bio-implant having screw body selectively formed with nanoporous in spiral groove and method of making the same | |
WO2006104644A2 (en) | Implants incorporating nanotubes and methods for producing the same | |
EP1696816B1 (en) | Arrangement with an implant and/or a unit belonging to said implant, and method for production of the implant and/or unit | |
US20040236338A1 (en) | Implant | |
JPH0731627A (en) | Implant and manufacture thereof | |
CN102232875B (en) | Biomedical implant structure with threaded structure and method for selective surface treatment thereof | |
RU2677271C1 (en) | Method of manufacturing micro-nanostructured porous layer on titanium implant surface | |
Chuan et al. | Effect of applied voltage on surface properties of anodised titanium in mixture of β-glycerophosphate (β-GP) and calcium acetate (CA) | |
KR100453289B1 (en) | Electrolyte solution for implant surface treatment and method of implant surface treatment using the same | |
KR100700027B1 (en) | Surface Modification Method of Titanium Implant by Microarc Oxidation | |
Park et al. | The effect of fluoride treatment on titanium treated with anodic spark oxidation | |
Kim et al. | Characterization of titanium implant anodized in various electrolytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |